Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Submitted by
admin
on September 10, 2023 - 8:03pm
Source:
Medical News Today
News Tags:
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
Headline:
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
snippet:
A small study showed promising results in using semaglutide to treat people with type 1 diabetes.
Type 1 diabetes is traditionally treated with daily insulin injections while semaglutide is only approved for people with type 2 diabetes.
Researchers want to expand their work to see if their results can be replicated.
If findings continue to show promise, this could represent a significant change in the understanding and treatment of type 1 diabetes.
Do Not Allow Advertisers to Use My Personal information